Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 12 Mar 2026 for Cytek Biosciences, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Philippe Busque: trading record in brief
Philippe Busque discloses dealings in Cytek Biosciences, Inc. to SEC (Form 4). In total, 9 filings cover trades dated from 20 March 2024 to 10 March 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 12 March 2026 came the latest disclosure, an option exercise in Cytek Biosciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Philippe Busque
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
2,049 sharesCommon StockSEC:0001991396-26-000001:0
1,536 sharesCommon StockSEC:0001991396-25-000002:0
1,536 sharesCommon StockSEC:0001415889-25-022523:0
1,024 sharesCommon StockSEC:0001415889-25-013978:0
2,049 sharesCommon StockSEC:0001415889-25-007890:0
1,536 sharesCommon StockSEC:0001415889-24-027369:0
1,536 sharesCommon StockSEC:0001415889-24-021854:0
6,659 sharesCommon StockSEC:0001415889-24-014144:0
5,464 sharesCommon StockSEC:0001415889-24-008881:0
9 of 9 declarations
